Incisive Surgical, Inc. is a privately-held medical device company established in 1999 with a focus on developing proprietary mechanical surgical solutions for skin closure. The company's flagship product, the INSORB Absorbable Skin Stapler, is a groundbreaking skin closure modality designed to deliver the cosmetic benefits of absorbable suture while offering the swift closure times associated with metal skin staplers. This innovative solution also eliminates the need for post-operative metal staple removal. The INSORB Absorbable Staple is composed of a co-polymer of polylactic acid and polyglycolic acid, which is absorbed over a period of a few months.
Based in the United States, Incisive Surgical operates within the Biotechnology and Pharmaceutical industries. The company's latest investment involved a $1.03M Debt Financing injection, dated 23 October 2009.
While the specifics of the investors behind this particular investment round were not provided, the company's innovative approach and focus on enhancing surgical procedures offer significant promise. Incisive Surgical's commitment to revolutionizing skin closure in the medical field presents an intriguing investment opportunity within the healthcare and biotechnology sectors.